New Strong Buy Stocks Apr 2026

: Labeled a "biotech breakout" by Citigroup with a maximum 1-year forecast of $242 , implying a potential 89% upside .

: Upgraded by Goldman Sachs and Oppenheimer after a record Q2 earnings beat. Analysts have set price targets as high as $297 , citing its dominant position in AI-driven electronic components. new strong buy stocks

As of late April 2026, several high-conviction "Strong Buy" ratings have emerged across the pharmaceutical, technology, and energy sectors, driven by record earnings beats and significant analyst price target upgrades. 🚀 Top Analyst Conviction Picks : Labeled a "biotech breakout" by Citigroup with